Related Experiment Video
Updated: Jun 4, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary
Sarah M Francis1, Subrata Chakrabarti, Frederick A Dick
1London Regional Cancer Program, London, Ontario, Canada.
Background:
The ability to respond to anti-growth signals is critical to maintain tissue homeostasis and loss of this negative growth control safeguard is considered a hallmark of cancer. Negative growth regulation generally occurs during the G0/G1 phase of the cell cycle, yet the redundancy and complexity among components of this regulatory network has made it difficult to discern how negative growth cues protect cells from aberrant proliferation.
Methodology/Principal Findings:
The retinoblastoma protein (pRB) acts as the final barrier to prevent cells from entering into the cell cycle. By introducing subtle changes in the endogenous mouse Rb1 gene (Rb1(ΔL)), we have previously shown that interactions at the LXCXE binding cleft are necessary for the proper response to anti-growth signals such as DNA damage and TGF-β, with minimal effects on overall development. This disrupts the balance of pro- and anti-growth signals in mammary epithelium of Rb1(ΔL/ΔL) mice. Here we show that Rb1(ΔL/ΔL) mice are more prone to mammary tumors in the Wap-p53(R172H) transgenic background indicating that negative growth regulation is important for tumor suppression in these mice. In contrast, the same defect in anti-growth control has no impact on Neu-induced mammary tumorigenesis.
Conclusions/Significance:
Our work demonstrates that negative growth control by pRB acts as a crucial barrier against oncogenic transformation. Strikingly, our data also reveals that this tumor suppressive effect is context-dependent.
Insights
Negative growth control by the retinoblastoma protein (pRB) is crucial for preventing cancer. This tumor suppression is context-dependent, highlighting its importance in specific cellular environments.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- Maintaining tissue homeostasis requires responding to anti-growth signals, a process often lost in cancer.
- Negative growth regulation, primarily in the G0/G1 cell cycle phase, is complex and vital for preventing aberrant proliferation.
Purpose of the Study:
- To investigate the role of retinoblastoma protein (pRB) interactions in negative growth control and tumor suppression.
- To determine if defects in pRB-mediated anti-growth signaling contribute to mammary tumorigenesis.
Main Methods:
- Generated Rb1(ΔL/ΔL) mice with altered pRB interactions at the LXCXE binding cleft.
- Assessed mammary tumor development in Rb1(ΔL/ΔL) mice on specific transgenic backgrounds (Wap-p53(R172H) and Neu).
Main Results:
- Rb1(ΔL/ΔL) mice exhibited increased susceptibility to mammary tumors in the Wap-p53(R172H) background, indicating pRB's tumor suppressive role.
- The defect in anti-growth control did not affect Neu-induced mammary tumorigenesis, suggesting context-dependent tumor suppression.
Conclusions:
- Negative growth control mediated by pRB is a critical barrier against oncogenic transformation.
- The tumor suppressive function of pRB-mediated negative growth control is context-dependent.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mitogens and the Cell Cycle
